Standards for reporting on surgery for chronic pancreatitis: a report from the International Study Group for Pancreatic Surgery (ISGPS).


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
07 2020
Historique:
received: 04 11 2019
revised: 23 01 2020
accepted: 02 02 2020
pubmed: 19 3 2020
medline: 1 9 2020
entrez: 19 3 2020
Statut: ppublish

Résumé

The International Study Group for Pancreatic Surgery provides globally accepted definitions for reporting of complications after pancreatic surgery. This International Study Group for Pancreatic Surgery project aims to provide a standardized framework for reporting of the results of operative treatment for chronic pancreatitis. An International Study Group for Pancreatic Surgery project circulation list was created with pre-existing and new members and including gastroenterologists in addition to surgeons. A computerized search of the literature was undertaken for articles reporting the operative treatment of chronic pancreatitis. The results of the literature search were presented at the first face-to-face meeting of this International Study Group for Pancreatic Surgery project group. A document outlining proposed reporting standards was produced by discussion during an initial meeting of the International Study Group for Pancreatic Surgery. An electronic questionnaire was then sent to all current members of the International Study Group for Pancreatic Surgery. Responses were collated and further discussed at international meetings in North America, Europe, and at the International Association of Pancreatology World Congress in 2019. A final consensus document was produced by integration of multiple iterations. The International Study Group for Pancreatic Surgery consensus standards for reporting of surgery in chronic pancreatitis recommends 4 core domains and the necessary variables needed for reporting of results: clinical baseline before operation; the morphology of the diseased gland; a new, standardized, operative terminology; and a minimum outcome dataset. The 4 domains combine to give a comprehensive framework for reports. Adoption of the 4 domains of the International Study Group for Pancreatic Surgery reporting standards for surgery for chronic pancreatitis will facilitate comparison of results between centers and help to improve the care for patients with this debilitating disease.

Sections du résumé

BACKGROUND
The International Study Group for Pancreatic Surgery provides globally accepted definitions for reporting of complications after pancreatic surgery. This International Study Group for Pancreatic Surgery project aims to provide a standardized framework for reporting of the results of operative treatment for chronic pancreatitis.
METHODS
An International Study Group for Pancreatic Surgery project circulation list was created with pre-existing and new members and including gastroenterologists in addition to surgeons. A computerized search of the literature was undertaken for articles reporting the operative treatment of chronic pancreatitis. The results of the literature search were presented at the first face-to-face meeting of this International Study Group for Pancreatic Surgery project group. A document outlining proposed reporting standards was produced by discussion during an initial meeting of the International Study Group for Pancreatic Surgery. An electronic questionnaire was then sent to all current members of the International Study Group for Pancreatic Surgery. Responses were collated and further discussed at international meetings in North America, Europe, and at the International Association of Pancreatology World Congress in 2019. A final consensus document was produced by integration of multiple iterations.
RESULTS
The International Study Group for Pancreatic Surgery consensus standards for reporting of surgery in chronic pancreatitis recommends 4 core domains and the necessary variables needed for reporting of results: clinical baseline before operation; the morphology of the diseased gland; a new, standardized, operative terminology; and a minimum outcome dataset. The 4 domains combine to give a comprehensive framework for reports.
CONCLUSION
Adoption of the 4 domains of the International Study Group for Pancreatic Surgery reporting standards for surgery for chronic pancreatitis will facilitate comparison of results between centers and help to improve the care for patients with this debilitating disease.

Identifiants

pubmed: 32183994
pii: S0039-6060(20)30073-8
doi: 10.1016/j.surg.2020.02.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-105

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Ajith K Siriwardena (AK)

Department of Surgery, Regional Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, United Kingdom. Electronic address: ajith.siriwardena@mft.nhs.uk.

John Windsor (J)

Department of Surgery, University of Auckland, New Zealand.

Nicholas Zyromski (N)

Department of Surgery, Indiana University School of Medicine, Indianapolis, IN.

Giovanni Marchegiani (G)

Clinic for Digestive Surgery, Pancreas Institute, Verona University Hospital, Italy.

Dejan Radenkovic (D)

Department of Surgery, Clinical Center of Serbia and School of Medicine, University of Belgrade, Serbia.

Catherine Morgan (C)

Department of Surgical Oncology, Medical University of South Carolina, Charleston, SC.

Ioannis Passas (I)

Department of Surgery, Metropolitan Hospital, Athens, Greece.

Attila Olah (A)

Department of Surgery, Petz Aladar Hospital, Gyor, Hungary.

Kevin C Conlon (KC)

Hepato-Pancreatico-Biliary Unit, Department of General Surgery, Trinity College Dublin, Tallaght Hospital, Ireland.

Martin Smith (M)

Department of Surgery, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.

Olivier Busch (O)

Department of Surgery, Amsterdam UMC, University of Amsterdam, The Netherlands.

Minas Baltatzis (M)

Department of Surgery, Regional Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, United Kingdom.

Marc G Besselink (MG)

Department of Surgery, Amsterdam UMC, University of Amsterdam, The Netherlands.

Charles Vollmer (C)

Department of Surgery, Penn Medicine, University of Pennsylvania, Philadelphia, PA.

Carlos Fernandez-Del Castillo (CF)

Department of Surgery, Massachusetts General Hospital and the Harvard Medical School, Boston, MA.

Helmut Friess (H)

Department of Hepato-Pancreato-Biliary Surgery, Klinikum rechts der Isar, Technische Universitat Munchen, Germany.

Giuseppe Garcea (G)

Department of Surgery, University Hospitals of Leicester, United Kingdom.

Sean Burmeister (S)

Department of General, Visceral, and Transplantation Surgery, University of Cape Town Health Sciences Faculty and Surgical Gastroenterology Unit Groote Schuur Hospital, South Africa.

Thilo Hackert (T)

Department of Surgery, University of Heidelberg, Germany.

Keith D Lillemoe (KD)

Department of Surgery, Massachusetts General Hospital and the Harvard Medical School, Boston, MA.

Richard Schulick (R)

Department of GI and HPB Surgical Oncology, University of Colorado School of Medicine, Aurora, CO.

Shailesh V Shrikhande (SV)

Pancreato-Biliary Unit, Tata Memorial Hospital, Mumbai, India.

Andrew Smith (A)

Department of Surgery, St James University Hospital, Leeds, United Kingdom.

Luca Gianotti (L)

Pancreatic Surgery Unit, School of Medicine and Surgery, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

Massimo Falconi (M)

Digestive Surgery Department, San Raffaele Scientific Institute, 'Vita-Salute' University, Milan, Italy.

David Adams (D)

Department of Surgical Oncology, Medical University of South Carolina, Charleston, SC.

Mustapha Adham (M)

Department of Surgery Lyon Civil Hospital, France.

Roland Andersson (R)

Dept of Hepato-Pancreato-Biliary Surgery, Clinical Sciences Lund, Lund University, Sweden.

Marco Del Chiaro (M)

Department of GI and HPB Surgical Oncology, University of Colorado School of Medicine, Aurora, CO.

John Devar (J)

Department of Surgery, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.

Santhalingam Jegatheeswaran (S)

Department of Surgery, Regional Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, United Kingdom.

Hjalmar van Santvoort (H)

Regional Academic Cancer Center Utrecht, The Netherlands.

Igor Khatkov (I)

Moscow Clinical Scientific Center, Moscow University of Medicine and Dentistry, Russian Federation.

Jakob Izbicki (J)

University Medical Center Hamburg-Eppendorf, Germany.

Markus Büchler (M)

Department of Surgery, University of Heidelberg, Germany.

John P Neoptolemos (JP)

Department of Surgery, University of Heidelberg, Germany.

Claudio Bassi (C)

Clinic for Digestive Surgery, Pancreas Institute, Verona University Hospital, Italy.

Christos Dervenis (C)

Department of Surgery, Metropolitan Hospital, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH